BUSINESS● LOW4h ago · Sep 16, 2026, 4:15 PM
Solid Biosciences wins new Outperform at RBC on DMD opportunity
Seeking Alpha Tech · global
Solid Biosciences received a new "Outperform" rating from RBC due to its Duchenne muscular dystrophy (DMD) opportunity. This indicates a positive outlook from financial analysts for the company's prospects.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS21m agoSA analyst warns Fed hike could deepen stagflation fearsSeeking Alpha TechBUSINESS21m agoPSB Holdings declares $0.18 dividendSeeking Alpha Tech